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Summary
Objectives: The objective of the present study was to evaluate the etiology, risk factors, and
patterns of antimicrobial resistance of intensive care unit (ICU)-acquired urinary tract infections
(UTIs) in patients admitted with sepsis.
Methods: In this observational study, 100 septic patients hospitalized in a general ICU were
selected. Demographic, clinical, and outcome data were obtained by chart review. Antibiotic
resistance/susceptibility was determined using the minimal inhibitory concentration (MIC)
technique.
Results: A UTI was present in 28 (28%) patients; the male to female ratio was 19:9 and the mean
age of the patients was 58.71  19.45 years. From the total of 28 isolates, 27 were resistant to
ciprofloxacin, 23 to amikacin, 27 to meropenem, 28 to cefepime, 26 to ceftazidime, and 27 to
ceftriaxone.
Conclusions: On the basis of our results, the rate of multidrug-resistant UTIs may be very high
in some ICUs in patients admitted with sepsis. This antimicrobial susceptibility/resistance
should be determined, and a special antimicrobial treatment protocol should be planned based* Corresponding author. Tel.: +98 21 88211524.
E-mail address: yunespanahi@bmsu.ac.ir (Y. Panahi).
1201-9712/$32.00 # 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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on the results for each ICU. The use of antibiotics for treating UTIs should be guided only
through this protocol because of the different spectra of pathogens and susceptibility patterns in
each ICU.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Figure 1 Study design.Introduction
Hospital-acquired urinary tract infections (UTIs) are the
most frequent nosocomial infections1 and are responsible
for 20—30% of nosocomial infections in medical or surgical
intensive care units (ICUs).2,3 The overall incidence density
of ICU-acquired UTIs may be as high as 9.6—11.3 per 1000 ICU
days.4,5
Nosocomial UTIs have been associated with a three-fold
increased risk for mortality in hospital-based studies (includ-
ing in ICUs), and may involve urosepsis, which carries a
mortality rate that may be as high as 25—60%. Nosocomial
UTIs often occur in patients with an indwelling urinary
catheter.4,6,7 Furthermore, several studies have associated
nosocomial UTIs with an increased length of hospital stay and
cost.4,8,9
In previous studies, the development of ICU-acquired UTIs
has been found to be more common in women4,5 and in
medical (9%) compared with non-cardiac surgical (6%) and
cardiac surgical patients (2%). It has also been shown to be
associated with the length of ICU stay4 and length of bladder
catheterization.10 Patients aged over 50 years, diabetic
patients, or patients who are immunocompromised are more
likely to develop a hospital-acquired UTI.11—13
Several microbial agents have been found to be respon-
sible for ICU-acquired UTIs such as Escherichia coli, Pseudo-
monas spp, Proteus mirabilis, Klebsiella spp, Enterobacter
spp, Staphylococcus spp, Enterococcus faecalis, Candida spp,
and Enterococcus spp.4,14 Antimicrobial resistance is a grow-
ing problem worldwide, especially in hospitals, where resis-
tant organisms are often first detected in ICUs. Previous
studies have demonstrated that the rates of antimicrobial
resistance are greater in bacteria isolated from ICUs com-
pared with other hospital wards and outpatient clinics,15 and
that hospitalization in ICUsmay be an independent risk factor
for acquiring infection bymultidrug-resistant strains.16 More-
over, ICU patients are often colonized with endemic, multi-
drug-resistant strains, which often spread to other wards.17
In one study, approximately 75% of Klebsiella pneumoniae,
87% of Enterobacter spp, 55% of Pseudomonas aeruginosa,
and 75% of methicillin-resistant Staphylococcus aureus
(MRSA) strains were drug-resistant to at least three different
classes.18
The incidence of resistance to antibiotics in bacteria
isolated from hospital-acquired infections varies among bac-
terial species, clinical settings, and even countries, and may
be related to local epidemic spread of a few colonies.19
Despite the importance of nosocomial UTIs in ICU patients,
there is a paucity of related data in the existing literature. It
is noteworthy that sepsis has been shown to be associated
with a high mortality rate of 30—50% and significant morbid-
ity despite advances in current medical care.20 This study
focused on septic patients as theymay be at increased risk for
acquiring antimicrobial resistant UTIs because of prior expo-sure to various types of antibiotics, a factor that is known to
play an important role in the generation of antimicrobial
resistance. The objective of the current study was to eval-
uate the etiology, risk factors, and patterns of antimicrobial
resistance of ICU-acquired UTIs in patients admitted with
sepsis.
Materials and methods
Setting and patients
In this observational study, 100 septic patients with symp-
toms of systemic inflammatory response syndrome (SIRS)
hospitalized in the general ICU of Sina Hospital, Tehran
University of Medical Sciences, Tehran, Iran between March
2004 and March 2005 were selected.
Patients older than 18 years of age with two or more SIRS
symptoms were included in the study. All the patients had an
indwelling urinary catheter. Figure 1 depicts the study
design.
Definitions
Patients with a positive urine culture (in catheterized
patients, one urine culture with a bacterial count >103
colony-forming units (CFU)/ml and no more than two bac-
terial species) first identified on ICU day 3 (48 hours) or later
were defined as having an ICU-acquired UTI. Patients with
positive urine cultures within 48 hours of ICU discharge were
also considered to have an ICU-acquired UTI. SIRS was defined
as the presence of fever or hypothermia (38 8C < T < 36 8C),
leukocytosis or leukopenia (12  109/l < leukocyte count <
4  109/l or band cell >10%), tachypnea (respiratory rate
>20/min or PCO2 <32 mmHg), and tachycardia (heart rate
>90 bpm). Sepsis was defined as SIRS with a proven or sus-
pected microbial etiology. Urosepsis was defined as sepsis in
the setting of aUTIwith a concomitantlypositiveblood culture
with the same organism within a 48-hour period.
Clinical evaluation
The following data were collected: demographic data (age,
sex), length of stay in ICU, indwelling catheter duration, and
fasting blood glucose (FBS). The score on the acute physiol-
ogy and chronic health evaluation (APACHE) II21 at admission
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blood pressure (BP) was assessed by means of a manual
sphygmomanometer in the early morning. Heart rate (HR)
was measured by heart auscultation for 1 min.
In order to control urinary output, a urinary catheter was
inserted for each patient. A closed prolonged urinary drai-
nage (indwelling catheter) system was used. The insertion of
the indwelling urethral catheter was performed after surgi-
cal hand washing, wearing sterile gloves, a facemask, and a
cap, and using sterile drapes. All the urine samples were
sterilely aspirated via the catheter lumen and were imme-
diately sent to the microbiology laboratory. A blood sample
was obtained from each patient and was sent to the labora-
tory for culture.
Laboratory evaluation
Blood cultures were done as routine. Urine culture was
performed quantitatively, and uropathogens were identified
according to routine laboratory methods.
Pathogen identification
In order to isolate and identify the pathogens, the urine
specimens were streaked onto nutrient agar plates in the
form of four-phase streaking patterns, and all the culture
plates were then incubated at 37 8C for 24—48 hours. After
colony formation, a second culture of each colony was done
in the same way in order to obtain a pure bacterial colony.
Bacterial species were identified by performing Gram stain-
ing and microscopic examination for each pure bacterial
colony. For Gram-negative bacteria their specific culture
medium was used. In order to identify P. aeruginosa, pure
Gram-negative bacteria were streaked onto a specific cetri-
mide agar plate andwere then incubated at 37 8C for 24 hours.
Colonies appearing bluish green or fluorescent yellow were
considered positive for P. aeruginosa. For identifying K. pneu-
moniae and E. coli, the specimenswere cultured separately on
eosin methylene blue (EMB) media and were examined after
being incubated at 37 8C for 24 hours. K. pneumoniae was
identified by the production of red-colored colonies and obser-
vation of the following biochemical results: fermentation of
glucose and lactose to acid and gas; positive results in the
Voges—Proskauer (VP), citrate, and urease tests; negative
results in methyl red, indole, and SH2 tests; and gelatin
liquefaction, where the growth of colony with metallic sheen
was considered E. coli.
For Gram-positive cocci, a catalase test was performed. In
order to distinguish S. aureus from coagulase-negative Sta-
phylococcus (CoNS), catalase-positive cocci were selected
and tested for mannitol fermentation and coagulation activ-
ity. The selected organism was considered S. aureus if the
results were positive and it was considered CoNS if the results
were negative.
Antibiotics
Antibiotic susceptibility was determined for the following
antibiotics: cefepime, ceftriaxone, ceftazidime, amikacin,
ciprofloxacin, and meropenem.
Antimicrobial susceptibility testing
Antibiotic resistance/susceptibility was determined by using
the minimal inhibitory concentration (MIC) technique. Forthis purpose, the broth microdilution method, which is a
known method in referral microbiology laboratories, was
utilized.22 Ten tubes, each containing 1 ml liquid Mueller—
Hinton broth (MHB) medium, were allotted for each bacterial
isolate; the exception was the first tube, which contained
2 ml. Antibiotic concentrations were prepared using a two-
fold method, as follows: (mg/ml) 64, 32, 16, 8, 4, 2, 1, and
0.5. The two last tubes were considered as controls for the
antibiotic and culture medium.
For the next step, 1 ml of microbial suspension equal to
0.5 McFarland standard was added to 100 ml liquid MHB, and
inoculum density of 105—106 CFU/ml of isolate was pre-
pared. One ml of microbial suspension obtained from the
culture media was then added to all the tubes except for
the controls, and all the tubes were subsequently incubated
at 37 8C for 24 hours before evaluation. The results were
recorded.
Evaluating MIC results
Turbidity due to organism growthwas evaluated for each tube
and was compared with the controls after the incubation
time was completed. MIC endpoints were defined as the
lowest concentration of antibiotic that resulted in no bac-
terial growth as indicated by the absence of turbidity. Sus-
ceptibility classification was performed in accordance with
the National Committee for Clinical Laboratory Standards
(NCCLS) criteria.23
Statistical analysis
Statistical analysis was performed using SPSS version 13.0 for
Windows. The obtained data on APACHE, length of stay in ICU,
duration of catheterization, and FBS were analyzed with an
independent sample t-test. Cross-tabulation (Chi-square
test) was used to analyze gender and age. A p-value less
than 0.05 was considered statistically significant.
Results
Demographics and correlations
A total of 100 septic patients with symptoms of SIRS hospi-
talized in the ICU were investigated during the 12-month
study period. UTI (bacteriuria) and urosepsis were present in
28 (28%) and six (6%) of the patients, respectively. For the
patients with a UTI (bacteriuric patients, N = 28), the male to
female ratio was 19:9 and the mean age was 58.71  19.45
years. For the non-bacteriuric patients (N = 72), the male to
female ratio was1.6/1 and mean age was 54.44  20.19
years.
The differences in the male to female ratio and age
between the bacteriuric and non-bacteriuric patients were
not statistically significant ( p = 0.61 and p = 0.34, respec-
tively). The ICU length of stay and mean APACHE score
showed no significant differences between the two groups
( p = 0.164 and p = 0.57, respectively). UTI was not signifi-
cantly correlated with the duration of catheterization
( p > 0.05). There were significantly higher levels of FBS
among the non-bacteriuric patients when compared with
the bacteriuric patients (mean = 169.57  91.63 mg/dl vs.
133.36  36.31 mg/dl, p = 0.04).
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Table 1 Antimicrobial resistance patterns of isolates
MIC resulta Urine isolate count Total
Klebsiella
pneumoniae
CoNS Pseudomonas
aeruginosa
Escherichia
coli
Ciprofloxacin S 0 0 0 0 0
RR 1 0 0 0 1
R 11 5 5 6 27
Amikacin S 3 0 0 0 3
RR 1 0 0 1 2
R 8 5 5 5 23
Meropenem S 0 0 0 0 0
RR 1 0 0 0 1
R 11 5 5 6 27
Cefepime S 0 0 0 0 0
RR 0 0 0 0 0
R 12 5 5 6 28
Ceftazidime S 2 0 0 0 2
RR 0 0 0 0 0
R 10 5 5 6 26
Ceftriaxone S 1 0 0 0 1
RR 0 0 0 0 0
R 11 5 5 6 27
CoNS, coagulase-negative Staphylococcus.
a S: susceptible; RR: relatively resistant; R: resistant.Microbiology
A total of 28 strains were identified in the urine cultures. K.
pneumoniae was the most common organism isolated from
the urine specimens (n = 12). Other organisms isolated were
E. coli (n = 6), CoNS (n = 5), and P. aeruginosa (n = 5). All the
infections due to CoNS and P. aeruginosa, except for one of
the pseudomonal infections, occurred after seven days of
catheterization.
All the isolates, except for one K. pneumoniae isolate that
showed a relative resistance (1 < MIC < 4), were resistant to
ciprofloxacin (MIC4). All the isolates, with the exception of
four K. pneumoniae isolates of which three were susceptible
(MIC 16) and one was relatively resistant (16 < MIC < 64),
and one E. coli that was relatively resistant, demonstrated
resistance to amikacin (MIC 64). From the total of 28
isolates, 27 were resistant to meropenem and cefepime
(MIC 16 and MIC 32, respectively). All the CoNS, P. aer-
uginosa, and E. coli isolates were resistant to ceftazidime
(MIC 32). Of the 12 K. pneumoniae isolates, two were
susceptible (MIC 8) and the others were resistant to cefta-
zidime (MIC 32). All the isolates, except for one K. pneu-
moniae isolate that was susceptible (MIC 4), showed
resistance to ceftriaxone (MIC 64). The antimicrobial resis-
tance patterns of the isolates are presented in Table 1.
Discussion
A UTI was present in 28 (28%) of our patients. Leone et al.
showed a 12% occurrence of catheter-associated UTI (CAUTI)
among ICU patients requiring an indwelling urinary cathe-
ter.24 The higher incidence observed in our study may be dueto the difference in the definition of bacteriuria where we
considered 104 CFU/ml density of isolate also as catheter-
associated bacteriuria; this factor was not included in the
latter study. A prospective study in which catheterized
patients were cultured daily via a technique capable of
detecting very low-level bacteriuria, as low as 1 CFU/ml,25
showed that the isolation of any microorganisms from an
intraluminal specimen, even 3—4 CFU/ml, is highly predic-
tive of CAUTI. If intercurrent antimicrobial therapy is not
given, the level of bacteriuria almost uniformly increases to
>105 within 24—48 hours, demonstrating the vulnerability of
the catheterized urinary tract to infection once any micro-
organisms gain access to the lumen of the catheter and the
bladder. Thus, most authorities consider concentrations>102
or 103 CFU/ml in urine collected with a needle from the
sampling port of the catheter, to be indicative of true CAUTI.
This concentration can be reproducibly detected in the
laboratory, and this definition is useful for therapeutic deci-
sions and epidemiologic research.26—28
The development of urosepsis in our patients was an infre-
quent event, occurring in 6% of the cases. Previously, Rosser
et al.7 demonstrated the same result in their retrospective
studyoncritically ill patientswithaurinary catheterwhere the
occurrence rate was reported as 15.8% of cases. The lower
frequency observed in our study may be due in part to the
difference in theevaluationof thepatients forurosepsiswhere
we did not include patients with positive urine culture and all
other cultures negative, a criterion considered by Rosser et al.
in their study. In the Laupland et al. study,4 1.37% of ICU-
acquired UTIs demonstrated association with a positive blood
culturewith the sameorganism.This smalldifference in results
may be due in part to the difference in the study population.
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bacteriuria in our septic patients, and the male to female
ratio showed no significant difference between the bacter-
iuric and non-bacteriuric patients. A number of studies in
general hospitals and some ICUs29,30 have shown that noso-
comial UTIs are more common in women, but this risk factor
has not been shown in most studies specific to ICU
patients.7,13
No differences were observed between the patients who
developed an ICU-acquired UTI and those patients who did
not with regard to either mean age or APACHE II score. Similar
results were observed in ICU patients in the Laupland et al.
studies.4,5
The ICU length of stay was not correlated with developing
ICU-acquired UTI in our septic ICU patients, which is in
contrast with results reported from previous studies on
non-selected ICU patients.4,5,30
Although diabetes mellitus has been previously reported
as a risk factor for CAUTI,26 the mean FBS levels did not show
such a correlation in our study. In fact, the mean FBS levels
were significantly higher in the non-bacteriuric compared
with the bacteriuric patients. Although this could be due to
more intensive care probably offered to the bacteriuric as
compared with non-bacteriuric patients, it may be a bias
caused by the small number of our cases.
One of the risk factors for CAUTI identified in previous
studies is prolonged catheterization.13,30 The duration of
catheterization was not present as a risk factor for UTI in
our septic patients; nevertheless, all the infections due to
CoNS and P. aeruginosa, except for one of the pseudomonal
infections, occurred after seven days of catheterization.
In total, the most common organism isolated from the
urine specimens of our patients was K. pneumonia, followed
by E. coli, CoNS, and P. aeruginosa. A national survey of
nosocomial UTIs in the USA found E. coli, Pseudomonas and
Klebsiella species among the top five pathogens,31 and many
authors have reported that Gram-negative bacteria have
greater isolation rates than other microorganisms in nosoco-
mial UTIs, as was seen in our study.32 Klebsiella species have
also been demonstrated to be among the top three UTI
causative agents in our country.33,34 However, unlike in our
study, most investigators have reported E. coli as the most
prevalent strain.4,35,14
We used the MIC method via the broth microdilution
technique to evaluate antimicrobial resistance. Good corre-
lation between this micro-technique and the standard agar
dilution method has been previously obtained. This method
of susceptibility testing is economically feasible to perform
on even a small number of isolates, and the endpoints are
easily interpretable.36
Interestingly in our study, all the 28 isolates were resistant
or relatively resistant to both meropenem and cefepime.
These two drugs are among the most common antibiotics in
ICU protocols. In the Savas et al. study, the resistance rate
against meropenem was determined as 20% for P. aerugi-
nosa.37 The Meropenem Yearly Susceptibility Test Informa-
tion Collection (MYSTIC) study group reported an incidence of
19% in 10 medical centers.38
Inhibitor resistance is an emerging problem making ther-
apy with cephalosporins a more difficult problem day by day.
Inhibitor-resistant organisms are also being increasingly
reported from various parts of the world.39,40 In additionto cefepime, resistance to ceftazidime and ceftriaxone was
significant in our study (26 and 27 of the isolates, respec-
tively). Previous studies have suggested that the selective
pressure from the use of antimicrobial agents is a major
determinant for the emergence of resistant strains.41,42
Recently, increased resistance has been observed against
third-generation cephalosporins for Gram-negative bacilli.43
High resistance rates to ciprofloxacin as a drug considered
highly effective in the treatment of UTIs was another finding
of our study. A study conducted on a pediatric population of
50 hospitalized patients with UTI showed 100% susceptibility
of E. coli to ciprofloxacin.44 However, with the widespread
use of fluoroquinolones, there have been reports of evolving
bacterial resistance to ciprofloxacin ranging from 10% to
53%.45 The very high rate of ciprofloxacin resistance among
organisms (27 of the isolates) observed in our study warrants
special attention and possibly is explained by the fact that
this is a setting with ciprofloxacin constituting one of the
commonly prescribed drugs.
Resistance to amikacin has been shown to be increasingly
progressive in Turkey.37 Resistance of Gram-negative aerobic
bacteria to aminoglycoside antibiotics differs according to
region and country. Resistance to aminoglycosides was found
to be higher in Southern Europe than in Central Europe and
Northern Europe.46 In the present study, the rate of amino-
glycoside resistance was found to be high (23 of the isolates
were resistant to amikacin).
The present study included 100 septic patients, 28 of
whom had a UTI. Therefore, the number of cases was very
small and did not allow statistical comparisons with signifi-
cant power. It could also be a possible answer to the question
of why we could not confirm the risk factors described in the
literature, although to our knowledge, no study has thus far
evaluated these risk factors in septic patients. A further
limitation of our study is that we did not consider some
factors such as prior use of antibiotics, admission reasons,
and prior hospitalization, which may play important roles in
developing antimicrobial resistance.
The susceptibility data collected from our septic patients
showed high resistance rates among CAUTI causative agents
to antibiotics commonly used in ICUs in these patients. The
high resistance rates observed in our study may be in part due
to the design of our study, as only septic patients were
included. These patients generally undergo various empiric
antimicrobial regimens and are, therefore, prone to develop
antimicrobial resistance. Another contributing factor could
be the poorly controlled antibiotic prescription and lack of a
well-defined antimicrobial treatment protocol in pre-ICU as
well as ICU settings in our country. Thus, antimicrobial
susceptibility/resistance should be determined and a special
antimicrobial treatment protocol should be planned based on
the results for each ICU. The use of antibiotics in the treat-
ment of UTIs should be guided only through such a protocol
because of the different spectra of pathogens and the sus-
ceptibility patterns in each ICU.
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